Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nisar

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
International Journal of Rheumatic Diseases|August 6, 2011
A challenging case of gout and failure of anti-TNF therapy- are current treatments adequate?Muhammad K Nisar, K Baburaj
International Journal of Nursing Studies|December 9, 2017
Rheumatology nurse specialists and corticosteroids prescription-Is it safe?Julie Begum, Muhammad K Nisar
European Journal of Rheumatology|March 16, 2017
Chikungunya and bilateral sacroiliitis-is there a link?Muhammad K Nisar, Christabel Packianathan
Mediterranean Journal of Rheumatology|May 13, 2024
Should All Patients Trial Subcutaneous Methotrexate Prior to Commencing Biologic Therapy? A Real World StudyAnem Mirza, Muhammad K Nisar
European Journal of Rheumatology|February 14, 2022
How well are biologic and conventional DMARDs tolerated in psoriatic arthritis: A real world studyIssrah I Jawad, Muhammed K Nisar
Annals of the Rheumatic Diseases|March 5, 2013
TNF antagonists and shingles: is vaccination advisable?Muhammad K Nisar, Andrew J K Ostor
The Practitioner|February 11, 2011
Disease remission the goal of therapy in rheumatoid arthritisMuhammad K Nisar, Andrew J K Ostör
Paediatric Respiratory Reviews|March 7, 2013
Pulmonary complications of biological therapies in children and adults with rheumatic diseasesMuhammad K Nisar, Andrew J K Ostör
European Journal of Rheumatology|November 30, 2019
Does biologic survival depend on co-prescribed methotrexate dose in established rheumatoid arthritis? A real-world studyNadira B Mothojakan, Janki Gore, Muhammad K Nisar
Rheumatology International|March 28, 2012
Interleukin-6 and cytochrome-P450, reason for concern?Sooha Kim, Andrew J K Östör, Muhammad K Nisar
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
International Journal of Rheumatic Diseases|August 6, 2011
A challenging case of gout and failure of anti-TNF therapy- are current treatments adequate?Muhammad K Nisar, K Baburaj
International Journal of Nursing Studies|December 9, 2017
Rheumatology nurse specialists and corticosteroids prescription-Is it safe?Julie Begum, Muhammad K Nisar
European Journal of Rheumatology|March 16, 2017
Chikungunya and bilateral sacroiliitis-is there a link?Muhammad K Nisar, Christabel Packianathan
Mediterranean Journal of Rheumatology|May 13, 2024
Should All Patients Trial Subcutaneous Methotrexate Prior to Commencing Biologic Therapy? A Real World StudyAnem Mirza, Muhammad K Nisar
European Journal of Rheumatology|February 14, 2022
How well are biologic and conventional DMARDs tolerated in psoriatic arthritis: A real world studyIssrah I Jawad, Muhammed K Nisar
Annals of the Rheumatic Diseases|March 5, 2013
TNF antagonists and shingles: is vaccination advisable?Muhammad K Nisar, Andrew J K Ostor
The Practitioner|February 11, 2011
Disease remission the goal of therapy in rheumatoid arthritisMuhammad K Nisar, Andrew J K Ostör
Paediatric Respiratory Reviews|March 7, 2013
Pulmonary complications of biological therapies in children and adults with rheumatic diseasesMuhammad K Nisar, Andrew J K Ostör
European Journal of Rheumatology|November 30, 2019
Does biologic survival depend on co-prescribed methotrexate dose in established rheumatoid arthritis? A real-world studyNadira B Mothojakan, Janki Gore, Muhammad K Nisar
Rheumatology International|March 28, 2012
Interleukin-6 and cytochrome-P450, reason for concern?Sooha Kim, Andrew J K Östör, Muhammad K Nisar
Pageof 11